BIOCON-ETC Joint Workshop 안내입니다. ———————————————– ㅇ 일시 : 2012.10.15(월) 13:00-18:00 ㅇ 장소 : 융기원 1층 A103호 ———————————————— Singapore 의 “Experimental Therapeutics Centre” 의 CEO 인 Alex Matter씨가 방문하여 BIOCON과 Joint Workshop을 진행합니다. 많은 관심과 참여바랍니다.
Dr. Tae Hee Kang publication was selected for the cover of JMB.
BIOCON, 2012.10.08, News, Notice, biocon, cover, kang, public-notice, publication, selected, 0Last August, Dr. Tae Hee Kang’s article was selected for the cover of JMB (Journal of Molecular Biology) Volume 423, Issue4, November 2012. “AIMP3/p18 Controls Translational Initiation by Mediating the Delivery of Charged Initiator tRNA to Initiation Complex” can be found on page 475-481. Also, the article was chosen as Featured Communication, and its Commentary was published. For more details,
Dr. Tae Hee Kang was published in JMB along with Commentary.
BIOCON, 2012.10.07, News, Notice, biocon, commentary, kang, public-notice, published, with, 0Dr. Kang’s publication was chosen as the featured communication article in JMB called “AIMP3/p18 Controls Translational Initiation by Mediating the Delivery of Charged Initiator tRNA to Initiation Complex.” Commentary about the article can be seen in JMB as well. For more details, please visit http://www.biocon.re.kr/28819.
The collaboration work about KRS with Scripps and Hebrew University got an approval to be published in Molecular Cell
BIOCON, 2012.10.02, News, Notice, collaboration, hebrew, public-notice, scripps, with, work, 0Dr. Min Guo from Scripps and Dr. Ehud Razin from Hebrew University collaborated with Bicon regarding KRS, and its article got an approval to be published in Molecular Cell. The title is “Structural Switch of Lysyl-tRNA Synthetase between Translation and Transcription.”
An article by SNU Prof. Sunghoon Kwon (Biocon PI) was selected as a front cover of Advanced Materials.
BIOCON, 2012.09.18, News, Notice, biocon, front, kwon, prof, public-notice, selected, sunghoon, 0The article written by Professor Sunghoon Kwon (Biocon PI) was chosen as the front cover of Advanced Materials. The article is about QR coded microparticle that can detect quack medicines when injected. More details will be informed.
An article written by Dr. Tae hee Kang was selected as a front cover art of JMB
BIOCON, 2012.09.18, News, Notice, biocon, cover, front, kang, public-notice, selected, written, 0On august 4th, the article written by Doctor Tae hee Kang was selected as the front cover art of JMB (Journal of Molecular Biology). The final cover of the article will be noticed when published. Its title is “AIMP3/p18 Controls Translational Initiation by Mediating the Delivery of Charged Initiator tRNA toInitiation Complex.” Please visit http://www.biocon.re.kr/28819 for more details.
Director Sunghoon Kim will be awarded from the National Academic of Sciences.
BIOCON, 2012.09.17, News, Notice, director, from, national, public-notice, sunghoon, will, 0Director Sunghoon Kim will be awarded from the National Academic of Sciences. Date: 9. 17. 2012 Place: The National Academic of Sciences, conference room (2nd floor) Time: 14:00~15:00
2012 BioKorea will be held and Biocon will host Medicinal Bio-convergence on 14th.
BIOCON, 2012.09.12, News, Notice, biocon, biokorea, held, host, public-notice, will, 02012 BioKorea will be held from 12th to 14th in Kintex. On 14th, Biocon will host Medicinal Bio-Convergence. On that day, Director Sunghoon Kim will give a speech about ” A role of universities in discovering new medicines.”
2012년 글로벌프론티어사업 혁신형 의약바이오컨버젼스 세부과제(신규) 추진계획 공고
BIOCON, 2012.08.22, News, Notice, public-notice, 바이오, 0교육과학기술부는 기존 기술의 한계를 돌파하는 세계최고의 원천기술 개발을 목표로 ‘글로벌프론티어사업’을 추진하고 있으며, 본 사업의 한 분야인 ‘혁신형 의약바이오컨버젼스연구’를 서울대학교 (재)의약바이오컨버젼스연구단에서 수행중에 있습니다. 이와 관련하여 2012년도 혁신형 의약바이오컨버젼스 연구분야의 신규 세부과제를 공모하오니 신청하여 주시기 바랍니다. □ 공모개요 ○ 지원대상: 국가 연구 과제 수행에 결격 사유가 없는 자 ○ 연구기간: 년 단위로 심사 후 업적 평가 및 지원여부 결정 ○ 공모기간: 2012년
김성훈 단장, 서울대 창의선도 중견연구자로 선정
BIOCON, 2012.07.30, News, Notice, public-notice, 바이오, 약학, 제약, 0의약바이오컨버젼스연구단 김성훈 단장(서울대 분자의학 및 바이오제약학과 교수)이 서울대학교 ‘2012년도 창의선도 중견연구자’로 선정됐다. 김 단장은 앞으로 3년간 매년 2억6000만원씩 연구비를 지원 받는다. 서울대학교는 26일 재직 교수 중에서 노벨상 수상자를 배출하기 위해 ‘2012년도 창의선도 연구자’ 사업지원 대상 8명을 선정해 연구비로 연간 최대 4억 원을 지원한다고 밝혔다. 이번 사업은 서울대학교가 법인화된 이후 추진해온 ‘글로벌 선도연구중심대학 육성사업’의 일환으로 연간 25억